Tigilanol tiglate
Tigilanol Tiglate
Tigilanol tiglate (pronunciation: ti-gi-la-nol ti-glate) is a novel small molecule drug derived from the seed of the tropical plant Fontainea picrosperma. It is used in veterinary medicine for the treatment of non-metastatic mast cell tumors in dogs.
Etymology
The name "tigilanol tiglate" is derived from the plant Fontainea picrosperma, commonly known as the tigil tree. The term "tiglate" refers to the ester or salt of tiglic acid, a naturally occurring unsaturated monocarboxylic acid.
Usage
Tigilanol tiglate is administered by injection directly into the tumor. It works by activating protein kinase C, which leads to tumor cell death and the body's immune response against the tumor.
Related Terms
- Protein kinase C: An enzyme that regulates various cellular functions and is activated by tigilanol tiglate.
- Mast cell tumor: A type of cancer in dogs that tigilanol tiglate is used to treat.
- Fontainea picrosperma: The plant from which tigilanol tiglate is derived.
- Veterinary oncology: The field of veterinary medicine that deals with cancer diagnosis and treatment, including the use of drugs like tigilanol tiglate.
Side Effects
Common side effects of tigilanol tiglate include pain or discomfort at the injection site, vomiting, and diarrhea. More serious side effects can include severe skin reactions at the injection site and systemic reactions like fever and lethargy.
See Also
External links
- Medical encyclopedia article on Tigilanol tiglate
- Wikipedia's article - Tigilanol tiglate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski